Prieels Pharma has a registered holding activity and consists mainly of financial fixed assets; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €115k and a net result of €74k. Equity is growing by ~113.1% per year across the filed fiscal years. Its solvency ranks better than 19% of 10252 sector peers (fiscal year 2025). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Outside the general model
Holding: general score not applicable
The company has a registered holding activity and financial fixed assets account for more than half of its assets. The general operating-company model is unsuitable for this profile, so we show no financial axes either. Filed figures remain available.
Credit advice for your own amount and term
Signals
Three signals. The signal on the left, the evidence on the right.
○neutral
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-08-2026, 24 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 4 filingsDeviation from the deadline
2025
24 d late
2024
7 d late
2023
33 d early
2022
18 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
18-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€115k▲ 180%
2024 · €41k
2022: €10k
2023: €28k
2024: €41k
2022 → 2025
Total assets
€1.29M▲ 367%
2024 · €276k
2022: €28k
2023: €47k
2024: €276k
2022 → 2025
Net result
€74k▲ 433%
2024 · €14k
2022: €8k
2023: €19k
2024: €14k
2022 → 2025
Working capital
€-60k
2024 · €265k
2022: €12k
2023: €27k
2024: €265k
2022 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line2022202320242025Trend
Equity€10k-€28k▲ 173%€41k▲ 46.6%€115k▲ 180%
Operating result€12k-€26k▲ 127%€18k▼ 30.8%€129k▲ 608%
Net result€8k-€19k▲ 131%€14k▼ 25.3%€74k▲ 433%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 608% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.29M
Fixed assets
€1.22M▲ 223,460%
Current assets
€66k▼ 75.9%
Equity and liabilities €1.29M
Equity
€115k▲ 180%
Debt
€1.17M▲ 399%
The debt ratio rises from 85.2% to 91.1%. Equity and debt are higher.
Key figures and ratios
Solvency
8.9%▼
2024 · 14.8%
ROE
64.3%▲
2024 · 33.8%
ROA
5.7%▲
2024 · 5.0%
Debt
€1.17M▲
2024 · €235k
Debt ≤ 1 year
€126k▲
2024 · €10k
Debt > 1 year
€1.05M▲
2024 · €225k
Income taxes
€21k▲
2024 · €5k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€276k€1.29M▲
Fixed assets21/28€546€1.22M▲
Tangible fixed assets22/27€546€208▼
Plant, machinery and equipment23-€208
Furniture and vehicles24€546-
Financial fixed assets28-€1.22M
Current assets29/58€275k€66k▼
Amounts receivable within one year40/41€41k€21k▼
Trade receivables40€35k€21k▼
Other amounts receivable41€5k€466▼
Cash at bank and in hand54/58€234k€45k▼
Deferred charges and accrued income490/1€637€331▼
Equity and liabilities
Total equity and liabilities10/49€276k€1.29M▲
Equity10/15€41k€115k▲
Contributions10/11€3k€3k=
Reserves13€25k€110k▲
Distributable reserves133€25k€110k▲
Profit (loss) carried forward14€13k€2k▼
Amounts payable17/49€235k€1.17M▲
Amounts payable after more than one year17€225k€1.05M▲
Financial debts170/4€225k€1.05M▲
Amounts payable within one year42/48€10k€126k▲
Current portion of amounts payable after more than one year42-€68k
Trade debts44€1k€1k▲
Suppliers440/4€1k€1k▲
Taxes, remuneration and social security45€8k€36k▲
Taxes450/3€8k€36k▲
Other amounts payable47/48€833€21k▲
Accrued charges and deferred income492/3€13€89▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€339€339=
Other operating charges640/8€443€472▲
Gross operating margin9900€19k€130k▲
Operating profit (loss)9901€18k€129k▲
Financial income75/76B€280€142▼
Recurring financial income75€280€142▼
Financial charges65/66B€60€34k▲
Recurring financial charges65€60€34k▲
Profit (loss) for the period before taxes9903€18k€95k▲
Income taxes67/77€5k€21k▲
Profit (loss) for the period9904€14k€74k▲
Profit (loss) for the period to be appropriated9905€14k€74k▲
Appropriation of the result
Profit (loss) to be appropriated9906€14k€87k▲
Profit (loss) brought forward from the previous period14P-€13k
Transfer to equity691/2€0€85k▲
To other reserves6921€0€85k▲
Profit to be distributed694/7€833-
Return on contributions (dividend)694€833-
The notes to these accounts (12 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
24-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 24 days late
2025
31-12
Financial
Highest result since 2022net €74k ▲433%
Operating result €129k, net result €74k, both a record.
31-12
Financial
Equity above €100kEq €115k ▲180%
4 profitable years in a row build equity to €115k.
07-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 7 days late
2024
31-12
Financial
Liquidity times 11current ratio 27.82
Current ratio from 2.43 to 27.82; short-term debt falls from €19k to €10k.
28-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
18-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 18 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Oud-Heverlee · 1 establishment unit since 2022
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Broekstraat 143050 Oud-HeverleeGround area
511 m²
Building footprint
212 m²
Volume, LiDAR
696 m³
Parcel 24086B0087/00R000, Flanders · tallest building 7.4 m, ±1 floor. Linked by address, not a title deed.
1 establishment unit
Prieels Pharma
since 20222.334.913.427
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24086B0087/00R000 | Flanders | 511 m² | 1 · 212 m² | 7.4 m · 1 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
PHARMARIVE
BE 0521.688.764
Etterbeek · Eq €115k
PHARMACIE JUPSIN
BE 0463.794.711
Hotton · Eq €115k
Holding La Pharma
BE 1021.147.605
Beveren-Kruibeke-Zwijndrecht · Eq €115k
APOTHEEK M. HEYLEN
BE 0422.188.639
Bocholt · Eq €114k
APOTHEEK ROSSEEL
BE 0816.622.412
Huldenberg · Eq €114k
Of 5,224 companies in sector 47730 we hold annual accounts for 3,863. 3,484 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded04-07-2022
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
64200Holdings
64210Activities of holding companies
70100Activities of head offices
70200Business and other management consultancy
70220Business consulting
82990Other business support services
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers
Data from official sources, last processed on 17-09-2026. Scores and ratios are computed by Checked and are not a credit decision.